UK doctors have been issued to stop prescriptions to four types of heartburn medications called Zanatac and ranitidine as a “precautionary measure”. The four drugs in question are Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets and Zantac 300mg Tablets. These include Zantac 75 Relief (PL 02855/0081 [GSL]) and Zantac 75 Tablets (PL 02855/0082 [P]. According to sources, MHRA is analyzing other ranitidine medicines which may also be possibly affected. “We have asked companies to quarantine batches of potentially affected medicines whilst we investigate and we will take action as necessary, including product recalls where appropriate.

Source: News 24 October 12, 2019 03:11 UTC